LONDON – Signifier Medical Technologies Ltd. closed an oversubscribed series B round, providing the means to generate more data for its neurostimulator, Snoozeal, in the treatment of obstructive sleep apnea (OSA), as well as to get a U.S. FDA nod for the device. Read More
